Facing fraud, U.S. FDA resets coronavirus antibody test market rules | ||
![]() The U.S. Food and Drug Administration on Monday said it would require antibody tests for the new coronavirus to undergo an agency review, reversing an earlier policy that had allowed fraudulent products to be marketed. |